Rajesh Shrotriya

Rajesh C.
Shrotriya currently works at Allos Therapeutics, Inc., as Director from 2012, Spectrum Pharmaceuticals Cayman LP, as Director, Shrotriya Family Foundation, as Director, University of Nevada, Las Vegas Foundation, as Trustee, and Cs Family Trust, as Trustee.
Dr. Shrotriya also formerly worked at Spectrum Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2002 to 2017, Bristol Myers Squibb Co., as Executive Director-Worldwide CNS Clinical Research, CASI Pharmaceuticals, Inc., as Director from 2014 to 2015, Antares Pharma, Inc., as Director from 2004 to 2011, Theralink Technologies, Inc. (Colorado), as Director, GT Biopharma, Inc., as Independent Director from 2021 to 2025, MGI PHARMA, Inc., as Chief Medical Officer & VP-Medical Affairs from 1994 to 1996, and SuperGen, Inc., as Chief Scientific Officer & Executive VP from 1996 to 2000.
Dr. Shrotriya received his undergraduate degree in 1962 from Dr. Bhim Rao Ambedkar University, undergraduate degree in 1967 from Armed Forces Medical College, and doctorate degree in 1974 from The Grant Government Medical College.